Joinder Agreement to Securities Exchange Agreement among iBasis, Inc., iBasis Global, Inc., U.S. Bank National Association, and Acceding Holders (May 29, 2003)

Summary

This agreement adds new investors (Acceding Holders) to a prior Securities Exchange Agreement between iBasis, Inc., iBasis Global, Inc., U.S. Bank National Association (as Agent), and other parties. The new investors agree to exchange their convertible notes for senior secured notes and warrants, and become bound by the terms of the original Exchange Agreement and related documents. The agreement confirms the investors' status as accredited investors and sets May 29, 2003, as the effective date. The company authorizes the issuance of new notes and warrants to these investors under specified limits.

EX-10.57 3 a2129229zex-10_57.htm EXHIBIT 10.57
QuickLinks -- Click here to rapidly navigate through this document


Exhibit 10.57


JOINDER AGREEMENT

        Reference is hereby made to the Securities Exchange Agreement dated as of February 21, 2003 (the "Exchange Agreement"), by and between the iBasis, Inc. (the "Company"), iBasis Global, Inc. ("Global" and, together with the Company, the "Borrower"), iBasis Securities Corporation, JMG Triton Offshore Fund Limited CITCO and the other Exchanging Holders named therein, and U.S. Bank National Association, as Collateral Agent, Fiscal Agent and Warrant Agent (the "Agent"). Capitalized terms used herein and not otherwise defined shall have the meanings assigned to such terms in the Exchange Agreement.

        Pursuant to the terms and conditions of the Exchange Agreement, the Borrower, the Agent and the persons set forth on Annex A hereto (the "Acceding Holders" and each, individually, an "Acceding Holder") and each person that becomes an Acceding Holder to this Joinder Agreement pursuant to Section 9 hereof hereby agree as follows:

        SECTION 1.    Subject to the terms and conditions of this Joinder Agreement, dated as of May 29, 2003 (this "Joinder Agreement"), each Acceding Holder hereby agrees to exchange, on or as of the Effective Date (as defined below), Convertible Notes in the aggregate principal amount set forth opposite such Acceding Holder's name on Annex A hereto for (a) the aggregate principal amount set forth opposite such Acceding Holder's name on Annex A hereto of the Borrower's 11.5% Senior Secured Notes due 2005 and (b) Warrants exercisable for an aggregate number of shares of Common Stock set forth opposite such Acceding Holder's name on Annex A hereto, all in accordance with the terms and conditions set forth in the Exchange Agreement. Each Acceding Holder hereby agrees to be bound by, and hereby requests the agreement of the Borrower and the Agent that such Acceding Holder shall be entitled to the benefits of, all of the terms, conditions and provisions of the Exchange Agreement as if such Acceding Holder had been one of the Persons originally executing the Exchange Agreement as an "Exchanging Holder"; provided that nothing herein shall be construed as making such Acceding Holder liable to the Borrower or the other Exchanging Holders or the Borrower liable to such Acceding Holder in respect of any acts or omissions of any party to the Exchange Agreement or in respect of any other event occurring prior to the Effective Date (as defined below) of this Joinder Agreement. Furthermore, each Acceding Holder expressly acknowledges and agrees that by executing and delivering this Joinder Agreement (i) it becomes a party to the Exchange Agreement, the Intercreditor Agreement and the Subordination Agreement, in each case as an "Exchanging Holder", (ii) it accepts and shall be subject to the terms of the Fiscal Agency Agreement and the Warrant Agreement as a Noteholder and a Warrantholder, respectively, and (iii) it accepts and shall be subject to the terms of each of the Credit Documents as an Exchanging Holder, as the same may be applicable.

        SECTION 2.    (a) Each Acceding Holder, subject to Section 2(b) below, severally, but not jointly with any other Acceding Holder, (i) represents and warrants that (A) it is duly and legally authorized to enter into this Joinder Agreement, (B) the execution, delivery and performance of this Joinder Agreement do not conflict with any provision of law or, if such Acceding Holder is not an individual, of the charter or by-laws of such Acceding Holder, or of any agreement binding on such Acceding Holder, and (C) all acts, conditions and things required to be done and performed and to have occurred prior to the execution, delivery and performance of this Joinder Agreement, and to render the same the legal, valid and binding obligation of such Acceding Holder, enforceable against it in accordance with its terms, have been done and performed and have occurred in due and strict compliance with all applicable laws; (ii) confirms that it has received a copy of the Exchange Agreement, together with such other documents and information as it has deemed appropriate to make its own credit analysis and decision to enter into this Joinder Agreement; (iii) agrees that it will, independently and without reliance upon the Exchanging Holders or the Agent and based on such documents and information as it shall deem appropriate at the time, continue to make its own credit decisions in taking or not taking action under the Exchange Agreement; (iv) appoints and authorizes the Agent to take such action as



agent on its behalf and to exercise such powers under the Exchange Agreement and the other Loan Documents as are delegated to the Agent by the terms thereof, together with such powers as are reasonably incidental thereto; and (v) agrees that it will perform in accordance with their terms all of the obligations which by the terms of the Exchange Agreement are required to be performed by it as an Exchanging Holder.

        (b) Each Acceding Holder, severally, but not jointly with any other Acceding Holder, represents and warrants only as to itself that, except as set forth on Schedule 2 attached hereto, it is an "accredited investor" as that term is defined in Rule 501 of Regulation D promulgated under the Securities Act, by virtue, inter alia, of its being (i) a corporation, Massachusetts or similar business trust, or partnership, not formed for the specific purpose of acquiring the Warrants or the shares of Common Stock issuable upon exercise of the Warrants, with total assets in excess of $5,000,000, (ii) a natural person whose individual net worth, or joint net worth with that person's spouse, at the time of his or her exchange exceeds $1,000,000, or (iii) a natural person who had an individual income in excess of $200,000 in each of the two most recent years or joint income with that person's spouse in excess of $300,000 in each of those years and has a reasonable expectation of reaching the same income level in the current year. The Company hereby waives the accredited investor representation set forth in Section 8.5 of the Exchange Agreement for those Acceding Holders set forth on Schedule 2.

        SECTION 3.    The Acceding Holders hereby request that the Borrower issue a new global note increasing the principal amount by $6,100,000 and a new global warrant increasing the number of shares exercisable thereunder by an aggregate of 1,116,605 shares of Common Stock; and the Company hereby authorizes and directs the Agent to authenticate and register, in the names and denominations specified herein, and to deliver each such Global Security, when so authenticated and registered, to The Depository Trust Company, or its custodian, on the Effective Date (as defined below).

        SECTION 4.    The effective date for this Joinder Agreement shall be May 29, 2003 (the "Effective Date"). Following the execution of this Joinder Agreement by the Borrower and the Acceding Holders, it will be delivered to the Agent for acceptance.

        SECTION 5.    By execution of this Joinder Agreement, the Borrower hereby certifies that: (i) the sum of the aggregate original principal amount of the Notes to be issued pursuant to this Joinder Agreement, together with the aggregate original principal amount of all other Notes previously issued under the Fiscal Agency Agreement, does not exceed $28,750,000; (ii) the sum of the aggregate amount of Warrant Shares issuable upon exercise of the Warrants to be issued pursuant to this Joinder Agreement, together with the aggregate amount of Warrant Shares issuable (or, if exercised, issued) upon exercise of all Warrants previously issued pursuant to any and all other Joinder Agreements entered into pursuant to (and after the date of) the Exchange Agreement (which, for avoidance of doubt, does not include any Warrants issued to the Exchanger, as that term is defined in and pursuant to the Exchange Agreement, or any Warrants issued pursuant to the Symphony Exchange Agreement) does not exceed 1,967,798; and (iii) this Joinder Agreement, and the Notes and Warrants to be issued pursuant thereto, constitutes a Permitted Exchange in accordance with Section 9.3 of, and otherwise is in accordance with, the Exchange Agreement.

        SECTION 6.    THIS JOINDER AGREEMENT SHALL FOR ALL PURPOSES BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE COMMONWEALTH OF MASSACHUSETTS (WITHOUT REGARD TO THE PRINCIPLES OF CONFLICTS OF LAWS).

        SECTION 7.    The use in this Joinder Agreement of neuter pronouns in reference to a party hereto shall be deemed to include the masculine or feminine, as the context may require.

        SECTION 8.    This Joinder Agreement may be executed in any number of counterparts which shall together constitute but one and the same agreement. This Joinder Agreement, once duly executed

2



and delivered in accordance with the terms of the Exchange Agreement, may be relied upon conclusively by the Agent.

        SECTION 9.    Any person that is a holder of Convertible Notes may become an Acceding Holder party to this Joinder Agreement by executing and delivering to the Borrower and the Agent, on or prior to June 30, 2003, an Instrument of Accession, substantially in the form of Annex B attached hereto, provided that the Borrower and the Agent consent to such person becoming an Acceding Holder party to this Joinder Agreement (which consent shall be conclusively deemed to have been given by the Borrower and Agent when each countersigns the Instrument of Accession executed by such person). Any such Instrument of Accession executed by any such person and countersigned by the Borrower and Agent shall become a part of this Joinder Agreement. It is hereby understood and agreed that each of Annex A and Schedule 2 shall be updated to reflect such Acceding Holder's interest. Any exchange of Convertible Notes for Notes by a holder of Convertible Notes who becomes an Acceding Party to this Joinder Agreement shall be deemed to have occurred for all purposes of this Joinder Agreement and such Convertible Notes as of the Effective Date, regardless of the date on which exchange may actually be consummated.

[Remainder of Page Intentionally Left Blank]

3


        IN WITNESS WHEREOF, intending to be legally bound, each of the undersigned has caused this Joinder Agreement to be executed on its behalf by its officer thereunto duly authorized, to take effect as a sealed instrument as of the date first above written.

    iBASIS, INC.

 

 

By:

/s/  OFER GNEEZY      
Name:  Ofer Gneezy
Title:    President and CEO

 

 

iBASIS GLOBAL, INC.

 

 

By:

/s/  RICHARD TENNANT      
Name:  Richard Tennant
Title:    Treasurer & CFO

 

 

ACCEDING HOLDERS
listed on
Annex A hereto

 

 

By:

 

COMMONWEALTH ADVISORS, INC.

their attorney in fact

 

 

 

 

By

/s/  WALTER MORALES      
Name:      Walter Morales
Title:        President
Address:  P.O. Box 3395
                 Baton Rouge, LA 70821
Acknowledged this 29 day of May, 2003:  

U.S. BANK NATIONAL ASSOCIATION,
as Collateral Agent under the Securities Exchange Agreement.

 

By:

/s/  JOHN BRENNAN      
Name:  John Brennan
Title:    Trust Officer

 


Annex A

Name of Acceding Holder

  Principal Amount of exchanged Convertible Notes
  Principal Amount of new Notes
  Number of Shares into which Warrants are exercisable
Ferguson, William & Janiece B.     70,000     35000   6407
Anepohl, Clarilynn D.     45,000     22000   4119
Breaux, Frank W.     100,000     50000   9153
Anepohl, Jr., Fred G.     35,000     18000   3203
Solar, Curtis J & Kay M     20,000     10000   1831
Attrep, John     90,000     45000   8237
Balcom, Grace, Randy & Carolyn     75,000     37000   6864
Ballard, E. Dwight     70,000     35000   6407
Ballard, Dwight & Sandra Jean     20,000     10000   1831
Balle, David S     35,000     18000   3203
Balliro, Peggy G     20,000     10000   1831
Williams, John Kelly     50,000     25000   4576
Bayard, William J     25,000     13000   2288
Anjier, Joseph L     90,000     45000   8237
Bombet MD, Leon H     100,000     50000   9153
Borak, Rachel     35,000     18000   3203
Brewer, Ralph     65,000     32000   5949
Bowman, Edwin A     35,000     18000   3203
Burroughs MD, Richard     175,000     87000   16017
Hirsch, Gary S. & Karen E     75,000     37000   6864
Hirsch, Gary S     130,000     65000   11898
Weldon, William E     170,000     85000   15559
Weldon, William & Cornelia     115,000     57000   10525
Newcomer, JR, George C     90,000     45000   8237
Cassidy, Laura     40,000     20000   3661
Pace, William Robert     70,000     35000   6407
CJS Investments     25,000     13000   2288
Claiborne, Earl B.     110,000     55000   10068
Claiborne, Earl B. & Ethel L.     25,000     13000   2288
Head & Neck P/S Plan, Clinic of     30,000     15000   2746
Head & Neck Pension Pln, Clinic     65,000     32000   5949
Collins, Steven & Eileen     30,000     15000   2746
De Fraites, Rebecca Kay     20,000     10000   1831
de Jongh, Maria P     20,000     10000   1831
De Fraites JR, Emanuel G     50,000     25000   4576
de Jongh, Alberto & Maria     160,000     80000   14644
Delhaye Children's Tr II     65,000     33000   5949
Mayfield, Mary Jo     115,000     57000   10525
Dement, Leon D. & Sylvia L.     75,000     37000   6864
Delhaye, Mary Field     25,000     13000   2288
Dupont, J. Benton     115,000     57000   10525
Dupont MD, J. Benton     30,000     15000   2746
Dyer, Herbert R.     180,000     90000   16475
Phillips, Gary N     210,000     105000   19220
Silverberg, Joel D     25,000     13000   2288
Trahan III, Victor "Trey"     130,000     65000   11898
Barry, Mary Kathleen V     200,000     100000   18305
Cloud, Louise C     60,000     30000   5492

Fazio, Frank L     45,000     23000   4119
Ferguson, William F     50,000     25000   4576
Mayfield FP, Field     65,000     32000   5949
Sanders, Donald Leroy     75,000     37000   6864
Fleury, JR, Linton Albert     55,000     27000   5034
Gasparrini, Sue D     25,000     13000   2288
Gasparrini, William G     65,000     32000   5949
Mayfield, Drew Generation Skippi     10,000     5000   915
Greco, Leu Anne     50,000     25000   4576
Greco TTEE, Cyrus John     100,000     50000   9153
Grissom MD, Robert T     25,000     13000   2288
Grissom MD, Robert T     15,000     8000   1373
Greco, Cyrus John     120,000     60000   10983
Haga, D Bruce     25,000     13000   2288
Hall MD, Donald Leroy     110,000     55000   10068
Kennon JR, Robert F     70,000     35000   6407
Harner, James Oliver     70,000     35000   6407
Hirsch, Karen Elkind     30,000     15000   2746
Haydel, Froisin J.     220,000     110000   20127
Haydel, F. Joseph & Frances L.     50,000     25000   4576
Mayfield Trust, John D.     25,000     13000   2288
Bayard, William J & Peggy G     30,000     15000   2746
Bayard, William J & Peggy G     15,000     8000   1373
Norman, Joseph R.     95,000     47000   8695
Norman, Joseph R. & Susan     15,000     8000   1373
BCL Investment Partnership     90,000     45000   8237
Kirsch JR, William G     40,000     20000   3661
Herad, Khosrow     55,000     27000   5034
Trahan III "Trey", Victor F     10,000     5000   915
Laville, Anne     50,000     25000   4576
Laville, Anne M.     40,000     20000   3661
Lee, David M     40,000     20000   3661
Lee, J. David     100,000     50000   9153
Lockwood, Thomas M.     25,000     13000   2288
La. Realtors Assoc LDF     50,000     25000   4576
Delhaye Trust, Mary Jo     10,000     5000   915
Maestri Jr., Natale A     25,000     13000   2288
Mayfield, Lucy R     40,000     20000   3661
Mayfield, Mary Jane     95,000     47000   8695
Cloyd, William P.     110,000     55000   10068
McMillin, Bill     70,000     35000   6407
McNeil, Edwin B     50,000     25000   4576
Mosley, Guy J & Wanda M     60,000     30000   5492
Mosley, Guy J     30,000     15000   2746
Mosley, Wanda M     40,000     20000   3661
Myres, Betty G     50,000     25000   4576
Myres, Yancey C     45,000     22000   4119
Shannon, Keith D     40,000     20000   3661
Noland, Ameila M     50,000     25000   4576
Ordeneaux, Jerry C.     140,000     70000   12814

Poche, Francis Jay     15,000     8000   1373
Pollard, Glenda S     65,000     32000   5949
Reine MD, Georgia A     20,000     10000   1831
Reine, Georgia A     175,000     87000   16017
Richey, Anne Q     70,000     35000   6407
Richey, Charles A     70,000     35000   6407
Richey, Charles A & Anne Q     60,000     30000   5492
Coleman & Partners, Robert     100,000     50000   9153
Russo III DDS, Camille Joseph     60,000     30000   5492
Russo, Camille J & Patricia     50,000     25000   4576
Russo III DDS MPP, Camille J     90,000     45000   8237
Rucci, Peter J     40,000     20000   3661
Schexnayder, Michael C. & Charl     25,000     13000   2288
Schexnayder MD, Michael C.     60,000     30000   5492
Schucker, Robert Charles     170,000     85000   15559
Schwartzberg, Harvey J     70,000     35000   6407
Schwartzberg, Harvey J & Betty     25,000     13000   2288
Schwartzberg, Ellis J. & Barb     55,000     27000   5034
Shannon, Maureen G     50,000     25000   4576
Drake, Kathryn M     15,000     8000   1373
Cloyd MD, William P.     210,000     105000   19220
Solar, Karen Kay     30,000     15000   2746
Mayfield Trust, Lucy R.     25,000     12000   2288
Steen, Gayle     175,000     87000   16017
Collins TTEE, Steven D     50,000     25000   4576
Stark, Michael M     80,000     40000   7322
Wood, Danny S.     15,000     8000   1373
Cavalier, MD, Steven J.     110,000     55000   10068
Alvarez, MD, Frank J.     100,000     50000   9153
Schwartzberg, MD, Glen     85,000     42000   7780
Robin, MD, Richard L.     140,000     70000   12814
Roberts, MD, Floyd J.     165,000     82000   15102
Melker MD, Merritt "Trey"     100,000     50000   9153
Dement, MD, Leon N.     190,000     95000   17390
Gladney, MD, William W.     100,000     50000   9153
Peairs, MD, Patricia T.     35,000     18000   3203
Hargus, MD, Louis Field     125,000     62000   11441
Waggenspack, MD, Mark     70,000     35000   6407
Silverberg, MD, Joel     25,000     13000   2288
Rolfsen, MD, Michael     80,000     40000   7322
Seiter, MD, Elizabeth D.     90,000     45000   8237
Vicari, MD, Roberta C.     50,000     25000   4576
Vath, MD, Richard R.     105,000     52000   9610
Silvey, Edgar H.     80,000     40000   7322
Hecker MD, Roger     35,000     17000   3203
Earhart MD, Robert N     115,000     57000   10525
Vinci, MD, Edmund     60,000     30000   5492
Fraser, MD, Warren M.     125,000     62000   11441
Thudium, Jr., John F.     165,000     82000   15102
Barry, Mary Kathleen     35,000     18000   3203

Garcia, O J     65,000     32000   5949
Waguespack, Hubert J.     140,000     70000   12814
Waguespack, Phillip J.     100,000     50000   9153
Wall IV, Williams D     45,000     23000   4119
Wall IV, Williams D     30,000     15000   2746
Walsh, Robert Eugene     20,000     10000   1831
Walsh, Robert & Linda     50,000     25000   4576
Williams, John Kelly     80,000     40000   7322
Wood, Danny S. & Leah S.     25,000     13000   2288
Wood, MD, Danny S.     110,000     55000   10068
Bernhard, Jo'An O     40,000     20000   3661
Zuckerman, Steven J.     50,000     25000   4576
Zuckerman, Steven & Marialden     45,000     23000   4119
Allen, Lane     65,000     33000   5949
Ashford, Jules     110,000     55000   10068
Bradford, Juanita     75,000     37000   6864
Ellison, Linda     50,000     25000   4576
Gust, Dorothy     10,000     5000   915
Gust, Richard     65,000     32000   5949
Salter, Barbara     45,000     23000   4119
Summers, Steven     30,000     15000   2746
Summers, Jane     10,000     5000   915
Summers, S & J     35,000     17000   3203

TOTAL:

 

$

11,770,000

 

$

5,884,000

 

1,077,248

Additional New Notes and Warrants to be held by iBasis until such time as additional Acceding Holders become party to this Joinder Agreement pursuant to Section 9 hereof.

 

$

430,000
—To be exchanged.

 

$

216,000

 

39,357

TOTAL:

 

 

12,200,000

 

$

6,100,000

 

1,116,605


Schedule 2


Schedule of Exceptions

Name of
Acceding Holder

  Principal Amount
of exchanged
Convertible Notes

  Principal Amount
of new Notes

  Number of Shares
into which Warrants
are exercisable

Allen, Lane   65,000   33,000   5,949
Ashford, Jules   110,000   55,000   10,068
Bradford, Juanita   75,000   37,000   6,864
Ellison, Linda S   50,000   25,000   4,576
Gust, Dorothy B   10,000   5,000   915
Gust, Richard   65,000   32,000   5,949
Salter, Barbara G   45,000   23,000   4,119
Summers, Steven Hall   30,000   15,000   2,746
Summers, Jane Kay   10,000   5,000   915
Summers, Steven & Jane K   35,000   17,000   3,203


Annex B


Instrument of Accession


[June    , 2003]

        Reference is made to that certain Joinder Agreement dated as of May 29, 2003, a copy of which is attached hereto (as amended and in effect from time to time, the "Joinder Agreement"), among iBasis, Inc. (the "Company"), iBasis Global, Inc. ("Global" and together with the Company, the "Borrower"), the Acceding Holders as named therein, and U.S. Bank National Association, as Collateral Agent, Fiscal Agent and Warrant Agent (the "Agent").

        The persons listed on Schedule 1 attached hereto are the owners or holders of the Company's 53/4% Convertible Subordinated Notes due 2005 and each person hereby agrees that, by his or her execution hereof, that it is an Acceding Holder party to the Joinder Agreement and that he or she is subject to all of the restrictions and conditions applicable to the Acceding Holders set forth in such Joinder Agreement. This Instrument of Accession shall take effect and shall become a part of said Joinder Agreement immediately upon acceptance thereof by the Borrower and the Agent. Attached hereto are revised Annex A and Schedule 2 to the Joinder Agreement.

        Executed as of the date set forth below under the laws of the Commonwealth of Massachusetts.


 

 

ACCEDING HOLDERS
listed on
Schedule 1 hereto

 

 

By:

COMMONWEALTH ADVISORS, INC.

their attorney in fact

 

 

By:


Name:
Title:
Address;    P.O. Box 3395
                   Baton Rouge, LA 70821

Accepted:
iBASIS, INC.

 

By:


Name:
Title:

 

iBASIS GLOBAL, INC.  

By:


Name:
Title:

 

U.S. BANK NATIONAL ASSOCIATION,
as Collateral Agent under the Securities Exchange Agreement.

 

By:


Name:
Title:

 


Schedule 1

Name of
Acceding Holder

  Principal Amount
of exchanged
Convertible Notes

  Principal Amount
of new Notes

  Number of Shares
into which Warrants
are exercisable

[List the Acceding Holders that are additional parties to the Joinder Agreement pursuant to Section 9 thereof.]




QuickLinks

    Exhibit 10.57
JOINDER AGREEMENT
    Annex A
    Schedule 2
Schedule of Exceptions
    Annex B
Instrument of Accession
[June , 2003]
    Schedule 1